Orthognathic surgery. Congenital malformation of face and neck, unspecified
Conditions
Interventions
Intervention 1: Intervention Group:Patients in this group will undergo general anesthesia with the implementation of an Enhanced Recovery After Surgery (ERAS) protocol and an ultrasound-guided trigemi
Sponsors
Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Patients Candidates for Orthognathic Surgery under General Anesthesia Primary deformity ASA Class I, II Filling out the Patient's Informed Consent Form
Exclusion criteria
Exclusion criteria: History of Opioid Usage History of Post -Operative Nausea and Vomiting
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Remifentanil Consumption During Operation. Timepoint: Every 1 hour During Operation. Method of measurement: Remifentan Infusion Dosage Based on Microgram.;Postoperative Analgesic consumption. Timepoint: 2 ,6,12,24 hours post operation. Method of measurement: Dosage of medications in miligram or gram. | — |
Secondary
| Measure | Time frame |
|---|---|
| Propofol Consumption During Operation. Timepoint: Every 1 hour during operation. Method of measurement: Propofol Consumption Based on Milligram per Hour.;Post-Op Visual Analogue Scale. Timepoint: Recovery and at 2, 4, 6, 12 and 24 hours. Method of measurement: Visual Analogue scale based on 0 to 10.;Incidence of Post -Operative Nausea and vomiting in 24 hrs. Timepoint: 2, 4, 6, 12 , 24 hours. Method of measurement: Patient expression.;Postop satisfaction score. Timepoint: before patient discharge. Method of measurement: scoring 1 to 5. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactElham Memary
Shahid Beheshti University of Medical Sciences
Outcome results
None listed